Literature DB >> 21505296

Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection.

Andrew Prendergast1, Hannah Goodliffe, Margaret Clapson, Robyn Cross, Gareth Tudor-Williams, Anna Riddell, Justin Daniels, Amanda Williams, Philip Goulder.   

Abstract

HIV-specific Elispot responses were investigated in 57 antiretroviral therapy-naive children, of median age 9.9 years. CD8(+) T-cell responses were detected in 96% children; Nef was the immunodominant protein. Responses broadened over time, but there was no association between magnitude, breadth or specificity of response and viraemia. Gag-specific CD4(+) T-cell responses, detectable in 26% children, correlated inversely with viraemia (R = -0.43, P < 0.001), suggesting that preservation of this cell population may be an important goal of therapeutic/vaccine strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21505296     DOI: 10.1097/QAD.0b013e3283478575

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

2.  Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.

Authors:  Jonathan Z Li; Chanson J Brumme; Michael M Lederman; Zabrina L Brumme; Hongying Wang; John Spritzler; Mary Carrington; Kathleen Medvik; Bruce D Walker; Robert T Schooley; Daniel R Kuritzkes
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

3.  Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.

Authors:  Emily Adland; Paolo Paioni; Christina Thobakgale; Leana Laker; Luisa Mori; Maximilian Muenchhoff; Anna Csala; Margaret Clapson; Jacquie Flynn; Vas Novelli; Jacob Hurst; Vanessa Naidoo; Roger Shapiro; Kuan-Hsiang Gary Huang; John Frater; Andrew Prendergast; Julia G Prado; Thumbi Ndung'u; Bruce D Walker; Mary Carrington; Pieter Jooste; Philip J R Goulder
Journal:  PLoS Pathog       Date:  2015-06-15       Impact factor: 6.823

4.  Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).

Authors:  Paolo Palma; Maria Luisa Romiti; Carla Montesano; Veronica Santilli; Nadia Mora; Angela Aquilani; Stefania Dispinseri; Hyppolite K Tchidjou; Marco Montano; Lars E Eriksson; Stefania Baldassari; Stefania Bernardi; Gabriella Scarlatti; Britta Wahren; Paolo Rossi
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 5.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

6.  CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller.

Authors:  Benjamin J Burwitz; Juan Pablo Giraldo-Vela; Jason Reed; Laura P Newman; Alexander T Bean; Francesca A Nimityongskul; Philip A Castrovinci; Nicholas J Maness; Enrique J Leon; Richard Rudersdorf; Jonah B Sacha
Journal:  Retrovirology       Date:  2012-11-06       Impact factor: 4.602

7.  Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.

Authors:  Marcus Buggert; Melissa M Norström; Chris Czarnecki; Emmanuel Tupin; Ma Luo; Katarina Gyllensten; Anders Sönnerborg; Claus Lundegaard; Ole Lund; Morten Nielsen; Annika C Karlsson
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

8.  Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Authors:  Paolo Palma; Lindvi Gudmundsdotter; Andrea Finocchi; Lars E Eriksson; Nadia Mora; Veronica Santilli; Angela Aquilani; Emma C Manno; Paola Zangari; Maria Luisa Romiti; Carla Montesano; Alba Grifoni; Andreas Brave; Karl Ljungberg; Pontus Blomberg; Stefania Bernardi; Eric Sandström; Bo Hejdeman; Paolo Rossi; Britta Wahren
Journal:  Vaccines (Basel)       Date:  2014-07-17

Review 9.  Immunity to HIV in Early Life.

Authors:  Maximilian Muenchhoff; Andrew J Prendergast; Philip Jeremy Renshaw Goulder
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

10.  HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.

Authors:  Tsungai Ivai Jongwe; Ros Chapman; Nicola Douglass; Shivan Chetty; Gerald Chege; Anna-Lise Williamson
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.